A Long-term Follow up Study of EXG102-031 in Participants With wAMD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Long-term Follow up Study of EXG102-031 in Participants With wAMD — Stella

Home/Wet Age-related Macular Degeneration/

View on ClinicalTrials.gov

Recruiting

Back to Wet Age-related Macular Degeneration trials

Trial locations(1 site)

China

Peking University People's Hospital, Beijing

Key details

Sponsor

Guangzhou Jiayin Biotech Ltd

Collaborators

Peking University People's Hospital

Enrollment target

~42 participants

Started

March 2025

Primary completion

May 2030

Age range

50 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.